Considerations for Drug Interactions on QTc in Exploratory COVID-19 Treatment.
Identifieur interne : 000668 ( Main/Exploration ); précédent : 000667; suivant : 000669Considerations for Drug Interactions on QTc in Exploratory COVID-19 Treatment.
Auteurs : Dan M. Roden ; Robert A. Harrington [États-Unis] ; Athena Poppas ; Andrea M. RussoSource :
- Circulation [ 1524-4539 ] ; 2020.
Descripteurs français
- KwdFr :
- Azithromycine (effets indésirables), Betacoronavirus (MeSH), Humains (MeSH), Hydroxychloroquine (effets indésirables), Infections à coronavirus (physiopathologie), Infections à coronavirus (traitement médicamenteux), Interactions médicamenteuses (physiologie), Pandémies (MeSH), Pneumopathie virale (physiopathologie), Pneumopathie virale (traitement médicamenteux), Rythme cardiaque (effets des médicaments et des substances chimiques), Rythme cardiaque (physiologie), Torsades de pointes (induit chimiquement), Torsades de pointes (physiopathologie), Troubles du rythme cardiaque (induit chimiquement), Troubles du rythme cardiaque (physiopathologie).
- MESH :
- effets des médicaments et des substances chimiques : Rythme cardiaque.
- effets indésirables : Azithromycine, Hydroxychloroquine.
- induit chimiquement : Torsades de pointes, Troubles du rythme cardiaque.
- physiologie : Interactions médicamenteuses, Rythme cardiaque.
- physiopathologie : Infections à coronavirus, Pneumopathie virale, Torsades de pointes, Troubles du rythme cardiaque.
- traitement médicamenteux : Infections à coronavirus, Pneumopathie virale.
- Betacoronavirus, Humains, Pandémies.
English descriptors
- KwdEn :
- Arrhythmias, Cardiac (chemically induced), Arrhythmias, Cardiac (physiopathology), Azithromycin (adverse effects), Betacoronavirus (MeSH), COVID-19 (MeSH), Coronavirus Infections (drug therapy), Coronavirus Infections (physiopathology), Drug Interactions (physiology), Heart Rate (drug effects), Heart Rate (physiology), Humans (MeSH), Hydroxychloroquine (adverse effects), Pandemics (MeSH), Pneumonia, Viral (drug therapy), Pneumonia, Viral (physiopathology), SARS-CoV-2 (MeSH), Torsades de Pointes (chemically induced), Torsades de Pointes (physiopathology).
- MESH :
- chemical , adverse effects : Azithromycin, Hydroxychloroquine.
- chemically induced : Arrhythmias, Cardiac, Torsades de Pointes.
- drug effects : Heart Rate.
- drug therapy : Coronavirus Infections, Pneumonia, Viral.
- physiology : Drug Interactions, Heart Rate.
- physiopathology : Arrhythmias, Cardiac, Coronavirus Infections, Pneumonia, Viral, Torsades de Pointes.
- Betacoronavirus, COVID-19, Humans, Pandemics, SARS-CoV-2.
DOI: 10.1161/CIRCULATIONAHA.120.047521
PubMed: 32267732
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Considerations for Drug Interactions on QTc in Exploratory COVID-19 Treatment.</title><author><name sortKey="Roden, Dan M" sort="Roden, Dan M" uniqKey="Roden D" first="Dan M" last="Roden">Dan M. Roden</name><affiliation><nlm:affiliation>Division of Cardiovascular Medicine and Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, TN (D.M.R.).</nlm:affiliation><wicri:noCountry code="subField">TN (D.M.R.).</wicri:noCountry></affiliation></author><author><name sortKey="Harrington, Robert A" sort="Harrington, Robert A" uniqKey="Harrington R" first="Robert A" last="Harrington">Robert A. Harrington</name><affiliation wicri:level="4"><nlm:affiliation>Department of Medicine, Stanford University, CA (R.A.H.).</nlm:affiliation><orgName type="university">Université Stanford</orgName><country>États-Unis</country><placeName><settlement type="city">Stanford (Californie)</settlement><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Poppas, Athena" sort="Poppas, Athena" uniqKey="Poppas A" first="Athena" last="Poppas">Athena Poppas</name><affiliation><nlm:affiliation>Cardiology Division, Brown University School of Medicine, Providence, RI (A.P.).</nlm:affiliation><wicri:noCountry code="subField">RI (A.P.).</wicri:noCountry></affiliation></author><author><name sortKey="Russo, Andrea M" sort="Russo, Andrea M" uniqKey="Russo A" first="Andrea M" last="Russo">Andrea M. Russo</name><affiliation><nlm:affiliation>Electrophysiology and Arrhythmia Services, Cooper University Hospital, Camden, NJ (A.M.R.).</nlm:affiliation><wicri:noCountry code="subField">NJ (A.M.R.).</wicri:noCountry></affiliation><affiliation><nlm:affiliation>Clinical Cardiac Electrophysiology Fellowship Program, Cooper Medical School of Rowan University, Camden, NJ (A.M.R.).</nlm:affiliation><wicri:noCountry code="subField">NJ (A.M.R.).</wicri:noCountry></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32267732</idno><idno type="pmid">32267732</idno><idno type="doi">10.1161/CIRCULATIONAHA.120.047521</idno><idno type="wicri:Area/Main/Corpus">000825</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000825</idno><idno type="wicri:Area/Main/Curation">000825</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000825</idno><idno type="wicri:Area/Main/Exploration">000825</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Considerations for Drug Interactions on QTc in Exploratory COVID-19 Treatment.</title><author><name sortKey="Roden, Dan M" sort="Roden, Dan M" uniqKey="Roden D" first="Dan M" last="Roden">Dan M. Roden</name><affiliation><nlm:affiliation>Division of Cardiovascular Medicine and Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, TN (D.M.R.).</nlm:affiliation><wicri:noCountry code="subField">TN (D.M.R.).</wicri:noCountry></affiliation></author><author><name sortKey="Harrington, Robert A" sort="Harrington, Robert A" uniqKey="Harrington R" first="Robert A" last="Harrington">Robert A. Harrington</name><affiliation wicri:level="4"><nlm:affiliation>Department of Medicine, Stanford University, CA (R.A.H.).</nlm:affiliation><orgName type="university">Université Stanford</orgName><country>États-Unis</country><placeName><settlement type="city">Stanford (Californie)</settlement><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Poppas, Athena" sort="Poppas, Athena" uniqKey="Poppas A" first="Athena" last="Poppas">Athena Poppas</name><affiliation><nlm:affiliation>Cardiology Division, Brown University School of Medicine, Providence, RI (A.P.).</nlm:affiliation><wicri:noCountry code="subField">RI (A.P.).</wicri:noCountry></affiliation></author><author><name sortKey="Russo, Andrea M" sort="Russo, Andrea M" uniqKey="Russo A" first="Andrea M" last="Russo">Andrea M. Russo</name><affiliation><nlm:affiliation>Electrophysiology and Arrhythmia Services, Cooper University Hospital, Camden, NJ (A.M.R.).</nlm:affiliation><wicri:noCountry code="subField">NJ (A.M.R.).</wicri:noCountry></affiliation><affiliation><nlm:affiliation>Clinical Cardiac Electrophysiology Fellowship Program, Cooper Medical School of Rowan University, Camden, NJ (A.M.R.).</nlm:affiliation><wicri:noCountry code="subField">NJ (A.M.R.).</wicri:noCountry></affiliation></author></analytic><series><title level="j">Circulation</title><idno type="eISSN">1524-4539</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Arrhythmias, Cardiac (chemically induced)</term><term>Arrhythmias, Cardiac (physiopathology)</term><term>Azithromycin (adverse effects)</term><term>Betacoronavirus (MeSH)</term><term>COVID-19 (MeSH)</term><term>Coronavirus Infections (drug therapy)</term><term>Coronavirus Infections (physiopathology)</term><term>Drug Interactions (physiology)</term><term>Heart Rate (drug effects)</term><term>Heart Rate (physiology)</term><term>Humans (MeSH)</term><term>Hydroxychloroquine (adverse effects)</term><term>Pandemics (MeSH)</term><term>Pneumonia, Viral (drug therapy)</term><term>Pneumonia, Viral (physiopathology)</term><term>SARS-CoV-2 (MeSH)</term><term>Torsades de Pointes (chemically induced)</term><term>Torsades de Pointes (physiopathology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Azithromycine (effets indésirables)</term><term>Betacoronavirus (MeSH)</term><term>Humains (MeSH)</term><term>Hydroxychloroquine (effets indésirables)</term><term>Infections à coronavirus (physiopathologie)</term><term>Infections à coronavirus (traitement médicamenteux)</term><term>Interactions médicamenteuses (physiologie)</term><term>Pandémies (MeSH)</term><term>Pneumopathie virale (physiopathologie)</term><term>Pneumopathie virale (traitement médicamenteux)</term><term>Rythme cardiaque (effets des médicaments et des substances chimiques)</term><term>Rythme cardiaque (physiologie)</term><term>Torsades de pointes (induit chimiquement)</term><term>Torsades de pointes (physiopathologie)</term><term>Troubles du rythme cardiaque (induit chimiquement)</term><term>Troubles du rythme cardiaque (physiopathologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Azithromycin</term><term>Hydroxychloroquine</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Arrhythmias, Cardiac</term><term>Torsades de Pointes</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Heart Rate</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="effets des médicaments et des substances chimiques" xml:lang="fr"><term>Rythme cardiaque</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Azithromycine</term><term>Hydroxychloroquine</term></keywords><keywords scheme="MESH" qualifier="induit chimiquement" xml:lang="fr"><term>Torsades de pointes</term><term>Troubles du rythme cardiaque</term></keywords><keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Interactions médicamenteuses</term><term>Rythme cardiaque</term></keywords><keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Drug Interactions</term><term>Heart Rate</term></keywords><keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Infections à coronavirus</term><term>Pneumopathie virale</term><term>Torsades de pointes</term><term>Troubles du rythme cardiaque</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Arrhythmias, Cardiac</term><term>Coronavirus Infections</term><term>Pneumonia, Viral</term><term>Torsades de Pointes</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à coronavirus</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Betacoronavirus</term><term>COVID-19</term><term>Humans</term><term>Pandemics</term><term>SARS-CoV-2</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Betacoronavirus</term><term>Humains</term><term>Pandémies</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32267732</PMID><DateCompleted><Year>2020</Year><Month>07</Month><Day>01</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1524-4539</ISSN><JournalIssue CitedMedium="Internet"><Volume>141</Volume><Issue>24</Issue><PubDate><Year>2020</Year><Month>06</Month><Day>16</Day></PubDate></JournalIssue><Title>Circulation</Title><ISOAbbreviation>Circulation</ISOAbbreviation></Journal><ArticleTitle>Considerations for Drug Interactions on QTc in Exploratory COVID-19 Treatment.</ArticleTitle><Pagination><MedlinePgn>e906-e907</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1161/CIRCULATIONAHA.120.047521</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Roden</LastName><ForeName>Dan M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine and Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, TN (D.M.R.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harrington</LastName><ForeName>Robert A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Department of Medicine, Stanford University, CA (R.A.H.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poppas</LastName><ForeName>Athena</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiology Division, Brown University School of Medicine, Providence, RI (A.P.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Russo</LastName><ForeName>Andrea M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Electrophysiology and Arrhythmia Services, Cooper University Hospital, Camden, NJ (A.M.R.).</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Cardiac Electrophysiology Fellowship Program, Cooper Medical School of Rowan University, Camden, NJ (A.M.R.).</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Circulation</MedlineTA><NlmUniqueID>0147763</NlmUniqueID><ISSNLinking>0009-7322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber><NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance></Chemical><Chemical><RegistryNumber>83905-01-5</RegistryNumber><NameOfSubstance UI="D017963">Azithromycin</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Protocol" UI="C000705127">COVID-19 drug treatment</SupplMeshName></SupplMeshList><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001145" MajorTopicYN="N">Arrhythmias, Cardiac</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017963" MajorTopicYN="N">Azithromycin</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="Y">Betacoronavirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004347" MajorTopicYN="N">Drug Interactions</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006339" MajorTopicYN="N">Heart Rate</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016171" MajorTopicYN="N">Torsades de Pointes</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">COVID-19</Keyword><Keyword MajorTopicYN="Y">arrhythmias, cardiac</Keyword><Keyword MajorTopicYN="Y">drug effects</Keyword><Keyword MajorTopicYN="Y">drug-related side effects and adverse reactions</Keyword><Keyword MajorTopicYN="Y">severe acute respiratory syndrome coronavirus 2</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32267732</ArticleId><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.047521</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>États-Unis</li></country><region><li>Californie</li></region><settlement><li>Stanford (Californie)</li></settlement><orgName><li>Université Stanford</li></orgName></list><tree><noCountry><name sortKey="Poppas, Athena" sort="Poppas, Athena" uniqKey="Poppas A" first="Athena" last="Poppas">Athena Poppas</name><name sortKey="Roden, Dan M" sort="Roden, Dan M" uniqKey="Roden D" first="Dan M" last="Roden">Dan M. Roden</name><name sortKey="Russo, Andrea M" sort="Russo, Andrea M" uniqKey="Russo A" first="Andrea M" last="Russo">Andrea M. Russo</name></noCountry><country name="États-Unis"><region name="Californie"><name sortKey="Harrington, Robert A" sort="Harrington, Robert A" uniqKey="Harrington R" first="Robert A" last="Harrington">Robert A. Harrington</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidStanfordV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000668 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000668 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidStanfordV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32267732
|texte= Considerations for Drug Interactions on QTc in Exploratory COVID-19 Treatment.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32267732" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidStanfordV1
| This area was generated with Dilib version V0.6.38. |  |